Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases

被引:7
|
作者
Werensteijn-Honingh, Anita M. [1 ]
Kroon, Petra S. [1 ]
Winkel, Dennis [1 ]
van Gaal, J. Carlijn [1 ]
Hes, Jochem [1 ]
Snoeren, Louk M. W. [1 ]
Timmer, Jaleesa K. [1 ]
Mout, Christiaan C. P. [1 ]
Bol, Gijsbert H. [1 ]
Kotte, Alexis N. [1 ]
Eppinga, Wietse S. C. [1 ]
Intven, Martijn [1 ]
Raaymakers, Bas W. [1 ]
Jurgenliemk-Schulz, Ina M. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiotherapy, HP Q00-3-11,POB 85500, NL-3508 GA Utrecht, Netherlands
关键词
Bowel; Duodenum; MR-linac; CBCT-linac; Stereotactic body radiotherapy; Lymph node metastases; RADIATION-THERAPY; ADAPTIVE RADIOTHERAPY; SBRT; FEASIBILITY; MOTION;
D O I
10.1016/j.phro.2022.06.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Magnetic resonance (MR)-linac delivery is expected to improve organ at risk (OAR) sparing. In this study, OAR doses were compared for online adaptive MR-linac treatments and conventional cone beam computed tomography (CBCT)-linac radiotherapy, taking into account differences in clinical workflows, especially longer session times for MR-linac delivery.Materials and methods: For 25 patients with pelvic/abdominal lymph node oligometastases, OAR doses were calculated for clinical pre-treatment and daily optimized 1.5 T MR-linac treatment plans (5 x 7 Gy) and compared with simulated CBCT-linac plans for the pre-treatment and online anatomical situation. Bowelbag and duodenum were re-contoured on MR-imaging acquired before, during and after each treatment session. OAR hard constraint violations, D0.5cc and D10cc values were evaluated, focusing on bowelbag and duodenum.Results: Overall, hard constraints for all OAR were violated less often in daily online MR-linac treatment plans compared with CBCT-linac: in 5% versus 22% of fractions, respectively. D0.5cc and D10cc values did not differ significantly. When taking treatment duration and intrafraction motion into account, estimated delivered doses to bowelbag and duodenum were lower with CBCT-linac if identical planning target volume (PTV) margins were used for both modalities. When reduced PTV margins were achievable with MR-linac treatment, bowelbag doses were lower compared with CBCT-linac. Conclusions: Compared with CBCT-linac treatments, the online adaptive MR-linac approach resulted in fewer hard planning constraint violations compared with single-plan CBCT-linac delivery. With respect to other bowelbag/duodenum dose-volume parameters, the longer duration of MR-linac treatment sessions negatively impacts the potential dosimetric benefit of daily adaptive treatment planning.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 50 条
  • [31] Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report
    Tyran, Marguerite
    Cao, Minsong
    Raldow, Ann C.
    Dang, Audrey
    Lamb, James
    Low, Daniel A.
    Steinberg, Michael L.
    Lee, Percy
    CUREUS, 2018, 10 (03):
  • [32] Based on 0.35 T magnetic resonance-guided radiotherapy, what are the nonisotropic PTV margins required for conventional prostate radiotherapy?
    Drabble, Joseph
    Das, Prantik
    George, Ben
    Camilleri, Philip
    Morris, Alex
    MEDICAL DOSIMETRY, 2022, 47 (04) : 334 - 341
  • [33] CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy
    Rodriguez, Lori L.
    Kotecha, Rupesh
    Tom, Martin C.
    Chuong, Michael D.
    Contreras, Jessika A.
    Romaguera, Tino
    Alvarez, Diane
    McCulloch, James
    Herrera, Robert
    Hernandez, Rene J.
    Mercado, Jairo
    Mehta, Minesh P.
    Gutierrez, Alonso N.
    Mittauer, Kathryn E.
    RADIOTHERAPY AND ONCOLOGY, 2022, 166 : 101 - 109
  • [34] Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer
    Darren M. C. Poon
    Bin Yang
    Hui Geng
    Oi Lei Wong
    Sin Ting Chiu
    Kin Yin Cheung
    Siu Ki Yu
    George Chiu
    Jing Yuan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 841 - 850
  • [35] Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy
    Subashi, Ergys
    Locastro, Eve
    Burleson, Sarah
    Apte, Aditya
    Zelefsky, Michael
    Tyagi, Neelam
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 32
  • [36] Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer
    Poon, Darren M. C.
    Yang, Bin
    Geng, Hui
    Wong, Oi Lei
    Chiu, Sin Ting
    Cheung, Kin Yin
    Yu, Siu Ki
    Chiu, George
    Yuan, Jing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 841 - 850
  • [37] Reduction in Normal Tissue Complication Probability by Stereotactic Magnetic Resonance-Guided Ablative Radiotherapy for Adrenal Lesions
    Chen, H.
    de Koste, J. R. van Sornsen
    Bohoudi, O.
    Bruynzeel, A.
    Slotman, B. J.
    Lagerwaard, F.
    Palacios, M.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S65 - S66
  • [38] Delta radiomics to track radiation response in lung tumors receiving stereotactic magnetic resonance-guided radiotherapy
    Zha, Yining
    Ye, Zezhong
    Zapaishchykova, Anna
    He, John
    Hsu, Shu-Hui
    Leeman, Jonathan E.
    Fitzgerald, Kelly J.
    Kozono, David E.
    Mak, Raymond H.
    Aerts, Hugo J. W. L.
    Kann, Benjamin H.
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 31
  • [39] Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
    Willigenburg, Thomas
    Beld, Ellis
    Hes, Jochem
    Lagendijk, Jan J. W.
    de Boer, Hans C. J.
    Moerland, Marinus A.
    van Zyp, Jochem R. N. van der Voort
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2020, 15 : 60 - 65
  • [40] Repeated Magnetic Resonance Image-guided Stereotactic body Radiotherapy for oligometastatic patients
    Panza, G.
    Chiloiro, G.
    Boldrini, L.
    Romano, A.
    Placidi, L.
    Nardini, M.
    Galetto, M.
    Cellini, F.
    Valentini, V.
    Gambacorta, M. A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1111 - S1112